Odyssey Health, Inc. Secures Multi-Million-Dollar, Nine-Year Service Contract and Financing Facility for Up to $25 Million
MWN-AI** Summary
On November 19, 2025, Odyssey Health, Inc. (OTCQB: ODYY), a medical device company specializing in life-saving medical solutions, announced the signing of a multi-million-dollar, nine-year maintenance service contract for a commercial medical property. This agreement is anticipated to create a stable and recurring revenue stream, a crucial milestone in the company's shift toward sustainable cash-generating operations. In conjunction with this contract, Odyssey secured a financing facility of up to $25 million, which enhances its financial flexibility for executing strategic initiatives.
The initial funding of $500,000 will be allocated toward advancing the recently introduced BreastCheck® sub-licensing program. “This agreement delivers predictable monthly cash flow and underscores our commitment to building recurring, scalable revenue," stated Michael Redmond, President and CEO of Odyssey Health. He emphasized that the financing facility positions the company to exploit growth opportunities across its diverse portfolio while aiming to boost long-term shareholder value.
Odyssey's recent activities, including the exclusive worldwide rights to BreastCheck®, a non-invasive screening test designed for the early detection of breast abnormalities, highlight its strengthening financial health and operational momentum. BreastCheck® utilizes temperature comparison technology to identify potential issues quickly, with results available within approximately 15 minutes, promoting early diagnosis and better patient outcomes.
With a corporate mission focused on acquiring and developing assets with significant clinical utility and market opportunities, Odyssey Health, Inc. is dedicated to delivering accessible, innovative medical solutions that can significantly impact global health. For further information, visit their official website or the dedicated page for BreastCheck®.
MWN-AI** Analysis
Odyssey Health, Inc. (OTCQB: ODYY), a medical device company dedicated to life-saving solutions, recently announced a multi-million-dollar, nine-year service contract alongside a financing facility of up to $25 million. This strategic move aims to bolster its cash-generating operations, creating a recurring revenue stream that investors should view as a positive indicator of long-term stability and growth potential.
The new service contract is pivotal, establishing a stable and predictable cash flow that can underlie future expansions and investments. Coupled with the financing facility, which initially allocates $500,000 towards the advancement of the company's innovative BreastCheck® sub-licensing program, Odyssey showcases its commitment to harnessing innovative technologies for profitability and market viability.
The BreastCheck® product, which facilitates non-invasive breast monitoring, aligns well with the growing demand for accessible and efficient healthcare solutions. By targeting a significant market need with innovative technology, Odyssey positions itself at the crossroads of substantial market opportunities and superior clinical utility, both important factors for sustainable business growth.
From a market perspective, the recent developments signal an improving financial trajectory for Odyssey. The combination of a long-term service contract and a substantial financing facility indicates not only operational commitment but also operational momentum that can instill confidence in investors. As the company leverages its resources to develop and commercialize its technologies, investors should monitor key milestones towards commercialization, reinforcing confidence in share value appreciation.
However, while the prospects are promising, potential investors should remain cautious about the inherent risks associated with small-cap health tech companies, such as market competition and execution risks. Therefore, maintaining a balanced investment approach, complemented by continuous analysis of Odyssey's performance and market dynamics, will be essential to capitalize on this promising opportunity.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
LAS VEGAS, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. (OTCQB: ODYY), a medical device company focused on developing and commercializing life-saving medical solutions, today announced it has entered into a multi-million-dollar, nine-year maintenance service contract for a commercial medical property. The long-term agreement creates a stable, recurring revenue stream and marks a significant step in Odyssey’s ongoing transition toward sustainable, cash-generating operations.
The Company has secured a financing facility of up to $25 million, providing enhanced financial flexibility to execute strategic initiatives. The initial tranche of $500,000 will be directed toward the advancement of Odyssey’s recently announced BreastCheck ® sub-licensing program.
“This agreement delivers predictable monthly cash flow and underscores our commitment to building recurring, scalable revenue,” said Michael Redmond, President and CEO of Odyssey Health, Inc. “The financing facility further positions us to capitalize on growth opportunities across our diversified portfolio and drive long-term shareholder value.”
The new facility services contract and financing facility follow a series of strategic transactions that highlight Odyssey’s strengthening financial position and operational momentum. Most recently, Odyssey entered into a sub-licensing agreement for exclusive, worldwide rights to BreastCheck ® , a rapid, non-invasive screening test for breast abnormalities.
About Odyssey Health, Inc.
Odyssey Health, Inc. (OTCQB: ODYY ) is a medical technology company with a focus in the area of life- saving medical solutions. Odyssey’s corporate mission is to create, acquire and accumulate distinct assets, intellectual properties, and exceptional technologies that provide meaningful medical solutions The Company is focused on building and acquiring assets in areas that have an identified technological advantage, provide superior clinical utility, have a substantial market opportunity. Odyssey Medical Devices, Inc is a wholly owned subsidiary of Odyssey Health Inc.
For more information, visit www.odysseyhealthinc.com .
About BreastCheck ®
BreastCheck ® , a product of Davion Healthcare PLC, is a safe, accurate and low-cost, way to routinely monitor for breast abnormalities and is intended to be an adjunct to established procedures for the detection of breast disease, such as clinical breast examination and mammography. Abnormalities within the breast frequently produce additional breast heat. BreastCheck ® averages temperature at three areas on each breast. By comparing the temperature of corresponding areas of one breast to the other and entering the results on the BreastCheck ® Mobile App, results can be interpreted immediately.
The BreastCheck ® test can be performed at home in approximately 15 minutes, providing immediate results that help identify potential breast abnormalities at an early stage. This innovative technology aligns with Odyssey’s mission to deliver accessible, life-saving diagnostic solutions that can meaningfully impact patient outcomes worldwide.
For more information about BreastCheck ® , visit: https://www.odysseyhealthinc.com/breastcheck
Contact:
Investor Relations
Odyssey Health, Inc.
Email: info@odysseyhealthinc.com
Forward-Looking Statements
This press release contains “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on management’s beliefs and assumptions and information currently available. The words "believe," "expect," "anticipate," "intend," "estimate," "project" and similar expressions that do not relate solely to historical matters identify forward-looking statements. Investors should be cautious in relying on forward-looking statements because they are subject to a variety of risks, uncertainties, and other factors that could cause actual results to differ materially from those expressed in any such forward-looking statements. These factors include, but are not limited to: the Company’s ability to successfully implement the facility service agreement; the Company’s ability to rely on predictable cash flows; the Company’s ability to utilize the financing facility to support strategic initiatives; the Company’s ability to capitalize on growth opportunities and drive long-term shareholder value; and the Company’s ability to advance the development and commercialization of the BreastCheck ® ; as well as other uncertainties described in our filings with the U.S. Securities and Exchange Commission. All information set forth is as of the date hereof unless otherwise indicated. You should consider these factors in evaluating the forward-looking statements.
FAQ**
How does Odyssey Health, Inc. (OTCQB: ODYY) plan to leverage the multi-million-dollar maintenance service contract to enhance its revenue streams and ensure long-term financial stability for Odyssey Group International Inc ODYY?
What specific strategic initiatives will the financing facility of up to $million support, and how does Odyssey Health, Inc. (OTCQB: ODYY) intend to use these funds to drive growth for Odyssey Group International Inc ODYY?
With the launch of BreastCheck ®, what competitive advantages does Odyssey Health, Inc. (OTCQB: ODYY) foresee in the market, and how does it align with the organizational goals of Odyssey Group International Inc ODYY?
Considering the recent strategic agreements by Odyssey Health, Inc. (OTCQB: ODYY), how does the company anticipate these developments will impact its operational momentum and overall market position for Odyssey Group International Inc ODYY?
**MWN-AI FAQ is based on asking OpenAI questions about Odyssey Group International Inc (OTC: ODYY).
NASDAQ: ODYY
ODYY Trading
0.0% G/L:
$0.0575 Last:
500 Volume:
$0.0575 Open:
